Orbimed Advisors - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$9,010,000
-68.9%
3,438,998
-37.1%
0.10%
-66.2%
Q2 2021$28,965,000
-21.4%
5,465,0300.0%0.29%
-14.8%
Q1 2021$36,834,000
-0.6%
5,465,0300.0%0.34%
+6.2%
Q4 2020$37,053,000
-9.6%
5,465,0300.0%0.32%
-37.1%
Q3 2020$40,988,000
-27.8%
5,465,030
+1.2%
0.52%
-35.5%
Q2 2020$56,783,000
+19.6%
5,402,7300.0%0.80%
+0.1%
Q1 2020$47,490,000
+273.3%
5,402,730
+56.7%
0.80%
+338.5%
Q4 2019$12,723,000
-3.0%
3,447,8400.0%0.18%
-26.9%
Q3 2019$13,119,000
-40.4%
3,447,8400.0%0.25%
-27.0%
Q2 2019$21,997,000
-22.9%
3,447,8400.0%0.34%
-22.7%
Q1 2019$28,514,000
+69.1%
3,447,8400.0%0.44%
+41.3%
Q4 2018$16,860,000
-50.5%
3,447,8400.0%0.31%
-23.9%
Q3 2018$34,030,000
-28.1%
3,447,8400.0%0.41%
-27.4%
Q2 2018$47,339,000
-13.3%
3,447,8400.0%0.56%
-16.5%
Q1 2018$54,579,000
+24.3%
3,447,840
+45.2%
0.68%
+21.8%
Q4 2017$43,919,000
-19.0%
2,375,2790.0%0.56%
+7.3%
Q3 2017$54,251,0002,375,2790.52%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Parallel Advisors, LLC 1$90.00%
View complete list of KALA PHARMACEUTICALS INC shareholders